OutSense Diagnostics

Toilet-based IoT Sensor for Detecting GI Conditions

Health Tech & Life Sciences
Acquired by undisclosed on Nov, 2022

Company Overview

Snapshot

Founded in January 2016 by Ishay Attar, OutSense Diagnostics operates with 11–50 employees. The company raised a total of $4.75 million across 5 funding rounds from 4 investors. In November 2022, OutSense Diagnostics was acquired by an undisclosed entity.

Business overview

OutSense Diagnostics develops an IoT sensor for wellness monitoring and early detection of illness, primarily focusing on preventing colorectal cancer by identifying hidden blood in stool. The company's core technology is a clip-on toilet sensor that uses imaging technologies to scan eliminations and communicate health parameters to a mobile app. This platform also serves other gastrointestinal conditions like irritable bowel syndrome, Crohn's disease, and colitis, as well as personalized nutrition applications, operating within the Health Tech & Life Sciences sector, specifically Digital Medical Diagnostics.

Strategic signal

In November 2020, OutSense Diagnostics secured an investment led by. This funding underscored the potential for non-invasive, continuous health monitoring solutions to transform early disease detection and preventative care in the health tech market.

Company Intelligence Q&A

What is OutSense Diagnostics' primary focus?
OutSense Diagnostics primarily focuses on developing a toilet-based IoT sensor for wellness monitoring and early detection of gastrointestinal conditions, with a key objective of preventing colorectal cancer by identifying hidden blood in stool.
When was OutSense Diagnostics acquired?
OutSense Diagnostics was acquired by an undisclosed entity in November 2022.
Which investor participated in OutSense Diagnostics' funding round in November 2020?
In November 2020, OutSense Diagnostics received funding led by.
What type of technology does OutSense Diagnostics utilize?
OutSense Diagnostics utilizes an IoT sensor with proprietary optical setup, data acquisition board, connectivity, and a mobile phone app to scan eliminations and detect health parameters.
What was a key development for OutSense Diagnostics in June 2021?
In June 2021, OutSense Diagnostics expanded its Series A funding with a new investment from Longevity Venture Partners.

External links